精优药业(00858)发盈警 预期中期亏损约4.5亿港元至4.8亿港元之间 同比盈转亏

智通财经
Nov 20, 2025

智通财经APP讯,精优药业(00858)发布公告,集团预期截至2025年9月30日止6个月将取得亏损约4.5亿港元与4.8亿港元之间,而对比截至2024年9月30日止6个月乃取得溢利。预期本期内转盈为亏主要由于就集团可换股债券投资的公平值确认未变现亏损,而于2024年相应期间同一项目则取得公平值变动的收益。该未变现亏损为非现金性质。在本期内,集团经营分类的表现维持稳定。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10